Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will present 16 abstracts featuring new data across its approved cancer therapies at the 2025 American Society of ...

Thus, the Work from Anywhere (WFA) revolution was born — a paradigm shift allowing employees to perform their duties from ...

We believe the recent presentation of our EEG-based placebo ... in patients characterized by a cognitive biomarker. The analysis prospectively demonstrated that weighting patient outcomes based ...

The incidence of OAC in short-segment BO is under 1 per 500 patients per year. Previous presentation: These data were presented in poster form at the annual meeting of the American Gastroenterological ...

On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation at the Society ... In experiment two, there was a comparative analysis of the therapeutic efficacy between ...

today announced the poster presentation of two abstracts at the 2025 American Society for Clinical Oncology (ASCO) Annual Meeting, taking place May 30-June 3 in Chicago. Title: Phase 1/2 Duravelo ...

"We are honored that our Trial in Progress poster has been accepted for presentation at ASCO 2025 ... thinking of our people and exacting analysis of our research processes.

Below is Validea's guru fundamental report for META PLATFORMS INC (META). Of the 22 guru strategies we follow, META rates highest using our P/E/Growth Investor model based on the published ...